New Model May Explain Differences in Parkinson’s Symptoms, Progression
A new model of alpha-synuclein in Parkinson’s development, addressing both where aggregates first appear and their spread…
Articles by Steve Bryson, PhD
YTX-7739 Works to Block SCD Enzyme at Well-Tolerated Doses, Yumanity Says
Dose-dependent decreases in targeted fatty acids were seen with YTX-7739, an investigational therapy for…
Brain Microbleeds in Patients Linked to Cognitive Decline, MRI Study Shows
Microbleeds found in the brains of people with Parkinson’s disease by magnetic resonance imaging (MRI) scans were…
Gocovri More Than Doubles ‘On’ Time Without Dyskinesia, Trial Data Show
Gocovri (amantadine) more than doubled the daily time on levodopa-based therapies without any…
Parkinson Canada Calls for Greater Support During Awareness Month
In light of Parkinson’s Awareness Month — starting April 1st — Parkinson Canada is…
microRNAs Show Potential as Biomarkers for Diagnosis, Predicting Outcomes
Several microRNAs in the blood of people with Parkinson’s disease differ from healthy…
Brain Cell Transplant Reverses Monkey’s Symptoms
Transplanting dopamine-producing nerve cells grown from monkeys’ own cells back into their brains relieved motor and depression symptoms…
Efficacy of Deep Brain Stimulation Depends on Type, Levodopa Response
The impact of deep brain stimulation (DBS) in improving motor function in people with Parkinson’s disease may…
Medication Adherence Didn’t Affect Patients’ Life Quality in Small Study
People with Parkinson’s disease who failed to take their medication as prescribed — meaning,…
AI Coupled With Videos of Movement May Help in Diagnosing Parkinson’s
Machine-learning analysis of video recordings of people thought to have Parkinson’s disease as they performed specific motor tasks…